NuPathe
NuPathe is a pharmaceutical company developing solutions for diseases of the CNS, including neurological and psychiatric disorders.
Funding reportedLast round: Post ipo debt
Follow NuPathe and see its new rounds in your feed.Start following
What company datasets say NuPathe raised
Funding, as reported
Reported in all101.6Min the source's currency
Rounds7
Last roundPost ipo debt
Last round dateNov 2012
Investors listed8
Exits
Exit
ExitBuyerPriceWhen
AcquiredEndo Health Solutions$105MDec 2013
IPONASDAQ:PATHundisclosedAug 2010
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put NuPathe in front of investors. Or tell us what we have wrong.